Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells

Hui Qin Wang, Deborah A. Altomare, Kristine L. Skele, Poulikos I. Poulikakos, Francis P. Kuhajda, Antonio Di Cristofano, Joseph R. Testa

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Activation of AKT and overexpression of fatty acid synthase (FAS) are frequently observed in human ovarian cancer. To explore a possible connection between AKT and FAS, immunohistochemical analyses were conducted on an ovarian cancer tissue microarray, which revealed a significant correlation between phosphorylated AKT (phospho-AKT) and expression of FAS. To investigate the relationship between phospho-AKT and FAS in vitro, a variety of experiments employing a specific phosphatidylinositol 3-OH kinase (PI3K) inhibitor (LY294002), inducible PTEN expression in PTEN-null cells, or AKT1 siRNA demonstrated that phosphatidylinositol-3 kinase (PI3K)/AKT signaling modulates FAS expression. In contrast, inhibition of FAS activity by the drug C75 resulted in downregulation of phospho-AKT and increased cell death. To explore the functional relationship between phospho-AKT and FAS, we used SKOV3, C200, and OVCAR10 ovarian carcinoma cells, which have constitutively active AKT, and OVCAR5 cells, which have very low basal phospho-AKT levels. Treatment with LY294002 abolished AKT activity and potentiated apoptosis induced by FAS inhibitors cerulenin or C75 only in cells with constitutively active AKT, suggesting that constitutive activation of AKT protects against FAS inhibitor-induced cell death. Furthermore, inhibition of FAS activity by cerulenin or C75 resulted in downregulation of phospho-AKT, which preceded the induction of apoptosis. To investigate the relationship between phospho-AKT and FAS in vivo, severe combined immunodeficient mice injected intraperitoneally with SKOV3 cells were treated with C75. Growth of SKOV3 xenografts was markedly inhibited by C75. Analysis of the levels of phospho-AKT and FAS in C75-treated tumors revealed concordant downregulation of phospho-AKT and FAS. Collectively, our findings are consistent with a working model in which AKT activation regulates FAS expression, at least in part, whereas FAS activity modulates AKT activation.

Original languageEnglish (US)
Pages (from-to)3574-3582
Number of pages9
JournalOncogene
Volume24
Issue number22
DOIs
StatePublished - May 19 2005
Externally publishedYes

Fingerprint

Fatty Acid Synthases
Carcinoma
Cerulenin
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Down-Regulation
Ovarian Neoplasms
Cell Death
Phosphatidylinositol 3-Kinase
Apoptosis
Null Lymphocytes
SCID Mice
Phosphatidylinositol 3-Kinases
Heterografts

Keywords

  • AKT/protein kinase B
  • Apoptosis
  • Fatty acid synthase
  • Ovarian cancer

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Wang, H. Q., Altomare, D. A., Skele, K. L., Poulikakos, P. I., Kuhajda, F. P., Di Cristofano, A., & Testa, J. R. (2005). Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Oncogene, 24(22), 3574-3582. https://doi.org/10.1038/sj.onc.1208463

Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. / Wang, Hui Qin; Altomare, Deborah A.; Skele, Kristine L.; Poulikakos, Poulikos I.; Kuhajda, Francis P.; Di Cristofano, Antonio; Testa, Joseph R.

In: Oncogene, Vol. 24, No. 22, 19.05.2005, p. 3574-3582.

Research output: Contribution to journalArticle

Wang, HQ, Altomare, DA, Skele, KL, Poulikakos, PI, Kuhajda, FP, Di Cristofano, A & Testa, JR 2005, 'Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells', Oncogene, vol. 24, no. 22, pp. 3574-3582. https://doi.org/10.1038/sj.onc.1208463
Wang, Hui Qin ; Altomare, Deborah A. ; Skele, Kristine L. ; Poulikakos, Poulikos I. ; Kuhajda, Francis P. ; Di Cristofano, Antonio ; Testa, Joseph R. / Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. In: Oncogene. 2005 ; Vol. 24, No. 22. pp. 3574-3582.
@article{3deab83f8653491c8fa7be86f9a30414,
title = "Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells",
abstract = "Activation of AKT and overexpression of fatty acid synthase (FAS) are frequently observed in human ovarian cancer. To explore a possible connection between AKT and FAS, immunohistochemical analyses were conducted on an ovarian cancer tissue microarray, which revealed a significant correlation between phosphorylated AKT (phospho-AKT) and expression of FAS. To investigate the relationship between phospho-AKT and FAS in vitro, a variety of experiments employing a specific phosphatidylinositol 3-OH kinase (PI3K) inhibitor (LY294002), inducible PTEN expression in PTEN-null cells, or AKT1 siRNA demonstrated that phosphatidylinositol-3 kinase (PI3K)/AKT signaling modulates FAS expression. In contrast, inhibition of FAS activity by the drug C75 resulted in downregulation of phospho-AKT and increased cell death. To explore the functional relationship between phospho-AKT and FAS, we used SKOV3, C200, and OVCAR10 ovarian carcinoma cells, which have constitutively active AKT, and OVCAR5 cells, which have very low basal phospho-AKT levels. Treatment with LY294002 abolished AKT activity and potentiated apoptosis induced by FAS inhibitors cerulenin or C75 only in cells with constitutively active AKT, suggesting that constitutive activation of AKT protects against FAS inhibitor-induced cell death. Furthermore, inhibition of FAS activity by cerulenin or C75 resulted in downregulation of phospho-AKT, which preceded the induction of apoptosis. To investigate the relationship between phospho-AKT and FAS in vivo, severe combined immunodeficient mice injected intraperitoneally with SKOV3 cells were treated with C75. Growth of SKOV3 xenografts was markedly inhibited by C75. Analysis of the levels of phospho-AKT and FAS in C75-treated tumors revealed concordant downregulation of phospho-AKT and FAS. Collectively, our findings are consistent with a working model in which AKT activation regulates FAS expression, at least in part, whereas FAS activity modulates AKT activation.",
keywords = "AKT/protein kinase B, Apoptosis, Fatty acid synthase, Ovarian cancer",
author = "Wang, {Hui Qin} and Altomare, {Deborah A.} and Skele, {Kristine L.} and Poulikakos, {Poulikos I.} and Kuhajda, {Francis P.} and {Di Cristofano}, Antonio and Testa, {Joseph R.}",
year = "2005",
month = "5",
day = "19",
doi = "10.1038/sj.onc.1208463",
language = "English (US)",
volume = "24",
pages = "3574--3582",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "22",

}

TY - JOUR

T1 - Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells

AU - Wang, Hui Qin

AU - Altomare, Deborah A.

AU - Skele, Kristine L.

AU - Poulikakos, Poulikos I.

AU - Kuhajda, Francis P.

AU - Di Cristofano, Antonio

AU - Testa, Joseph R.

PY - 2005/5/19

Y1 - 2005/5/19

N2 - Activation of AKT and overexpression of fatty acid synthase (FAS) are frequently observed in human ovarian cancer. To explore a possible connection between AKT and FAS, immunohistochemical analyses were conducted on an ovarian cancer tissue microarray, which revealed a significant correlation between phosphorylated AKT (phospho-AKT) and expression of FAS. To investigate the relationship between phospho-AKT and FAS in vitro, a variety of experiments employing a specific phosphatidylinositol 3-OH kinase (PI3K) inhibitor (LY294002), inducible PTEN expression in PTEN-null cells, or AKT1 siRNA demonstrated that phosphatidylinositol-3 kinase (PI3K)/AKT signaling modulates FAS expression. In contrast, inhibition of FAS activity by the drug C75 resulted in downregulation of phospho-AKT and increased cell death. To explore the functional relationship between phospho-AKT and FAS, we used SKOV3, C200, and OVCAR10 ovarian carcinoma cells, which have constitutively active AKT, and OVCAR5 cells, which have very low basal phospho-AKT levels. Treatment with LY294002 abolished AKT activity and potentiated apoptosis induced by FAS inhibitors cerulenin or C75 only in cells with constitutively active AKT, suggesting that constitutive activation of AKT protects against FAS inhibitor-induced cell death. Furthermore, inhibition of FAS activity by cerulenin or C75 resulted in downregulation of phospho-AKT, which preceded the induction of apoptosis. To investigate the relationship between phospho-AKT and FAS in vivo, severe combined immunodeficient mice injected intraperitoneally with SKOV3 cells were treated with C75. Growth of SKOV3 xenografts was markedly inhibited by C75. Analysis of the levels of phospho-AKT and FAS in C75-treated tumors revealed concordant downregulation of phospho-AKT and FAS. Collectively, our findings are consistent with a working model in which AKT activation regulates FAS expression, at least in part, whereas FAS activity modulates AKT activation.

AB - Activation of AKT and overexpression of fatty acid synthase (FAS) are frequently observed in human ovarian cancer. To explore a possible connection between AKT and FAS, immunohistochemical analyses were conducted on an ovarian cancer tissue microarray, which revealed a significant correlation between phosphorylated AKT (phospho-AKT) and expression of FAS. To investigate the relationship between phospho-AKT and FAS in vitro, a variety of experiments employing a specific phosphatidylinositol 3-OH kinase (PI3K) inhibitor (LY294002), inducible PTEN expression in PTEN-null cells, or AKT1 siRNA demonstrated that phosphatidylinositol-3 kinase (PI3K)/AKT signaling modulates FAS expression. In contrast, inhibition of FAS activity by the drug C75 resulted in downregulation of phospho-AKT and increased cell death. To explore the functional relationship between phospho-AKT and FAS, we used SKOV3, C200, and OVCAR10 ovarian carcinoma cells, which have constitutively active AKT, and OVCAR5 cells, which have very low basal phospho-AKT levels. Treatment with LY294002 abolished AKT activity and potentiated apoptosis induced by FAS inhibitors cerulenin or C75 only in cells with constitutively active AKT, suggesting that constitutive activation of AKT protects against FAS inhibitor-induced cell death. Furthermore, inhibition of FAS activity by cerulenin or C75 resulted in downregulation of phospho-AKT, which preceded the induction of apoptosis. To investigate the relationship between phospho-AKT and FAS in vivo, severe combined immunodeficient mice injected intraperitoneally with SKOV3 cells were treated with C75. Growth of SKOV3 xenografts was markedly inhibited by C75. Analysis of the levels of phospho-AKT and FAS in C75-treated tumors revealed concordant downregulation of phospho-AKT and FAS. Collectively, our findings are consistent with a working model in which AKT activation regulates FAS expression, at least in part, whereas FAS activity modulates AKT activation.

KW - AKT/protein kinase B

KW - Apoptosis

KW - Fatty acid synthase

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=19944374798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944374798&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1208463

DO - 10.1038/sj.onc.1208463

M3 - Article

C2 - 15806173

AN - SCOPUS:19944374798

VL - 24

SP - 3574

EP - 3582

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 22

ER -